In vitro evaluation of photo-crosslinkable chitosan-lactide hydrogels for bone tissue engineering
Sungwoo Kim
Department of Orthopedic Surgery, Stanford University, Stanford, California
Search for more papers by this authorYunqing Kang
Department of Orthopedic Surgery, Stanford University, Stanford, California
Search for more papers by this authorÁngel E. Mercado-Pagán
Department of Orthopedic Surgery, Stanford University, Stanford, California
Search for more papers by this authorWilliam J. Maloney
Department of Orthopedic Surgery, Stanford University, Stanford, California
Search for more papers by this authorYunzhi Yang
Department of Orthopedic Surgery, Stanford University, Stanford, California
Department of Materials Science and Engineering, Stanford University, Stanford, California
Search for more papers by this authorSungwoo Kim
Department of Orthopedic Surgery, Stanford University, Stanford, California
Search for more papers by this authorYunqing Kang
Department of Orthopedic Surgery, Stanford University, Stanford, California
Search for more papers by this authorÁngel E. Mercado-Pagán
Department of Orthopedic Surgery, Stanford University, Stanford, California
Search for more papers by this authorWilliam J. Maloney
Department of Orthopedic Surgery, Stanford University, Stanford, California
Search for more papers by this authorYunzhi Yang
Department of Orthopedic Surgery, Stanford University, Stanford, California
Department of Materials Science and Engineering, Stanford University, Stanford, California
Search for more papers by this authorAbstract
Here we report the development and characterization of novel photo-crosslinkable chitosan-lactide (Ch-LA) hydrogels for bone tissue engineering. We synthesized the hydrogels based on Ch, LA, and methacrylic anhydride (MA), and examined their chemical structures, degradation rates, compressive moduli, and protein release kinetics. We also evaluated the cytotoxicity of the hydrogels and delivery efficacy of bone morphogenetic protein-2 (BMP-2) on osteoblast differentiation and mineralization using W-20-17 preosteoblast mouse bone marrow stromal cells and C2C12 mouse myoblast cells. NMR and FTIR revealed that the hydrogels were formed via amidation and esterification between Ch and LA, and methacrylation for photo-crosslinkable networks. Addition of a hydrophobic LA moiety to a hydrophilic Ch chain increased swellability, softness, and degradation rate of the photo-crosslinkable Ch-LA hydrogels. Changes in Ch/LA ratio and UV exposure time significantly affected compressive modulus and protein release kinetics. The photo-crosslinkable Ch-LA hydrogels were not cytotoxic regardless of the composition and UV crosslinking time. Higher alkaline phosphatase activities of both W-20-17 and C2C12 cells were observed in the less-crosslinked hydrogels at day 5. Mineralization was enhanced by sustained BMP-2 release from the hydrogels, but was cell type dependent. This photo-crosslinkable Ch-LA hydrogel is a promising carrier for growth factors. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 1393–1406, 2014.
Supporting Information
Additional Supporting Information may be found in the online version of this article.
| Filename | Description |
|---|---|
| jbmb33118-sup-0001-suppinfo.doc39 KB | Supplementary Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Uebersax L, Merkle HP, Meinel L. Biopolymer-based growth factor delivery for tissue repair: From natural concepts to engineered systems. Tissue Eng Part B Rev 2009; 15: 263–289.
- 2Vo TN, Kasper FK, Mikos AG. Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev 2012; 64: 1292–1309.
- 3Jeon O, Powell C, Solorio LD, Krebs MD, Alsberg E. Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels. J Control Release 2011; 154: 258–266.
- 4Pitarresi G, Casadei MA, Mandracchia D, Paolicelli P, Palumbo FS, Giammona G. Photocrosslinking of dextran and polyaspartamide derivatives: A combination suitable for colon-specific drug delivery. J Control Release 2007; 119: 328–338.
- 5Leach JB, Schmidt CE. Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds. Biomaterials 2005; 26: 125–135.
- 6Billiet T, Vandenhaute M, Schelfhout J, Vlierberghe SV, Dubruel P. A review of trends and limitations in hydrogel-rapid prototyping for tissue engineering. Biomaterials 2012; 33: 6020–6041.
- 7Lee JY, Nam SH, Im SY, Park YJ, Lee YM, Seol YJ, Chung CP, Lee SJ. Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J Control Release 2002; 78: 187–197.
- 8Tabata Y. Tissue regeneration based on growth factor release. Tissue Eng 2003; 9 (Suppl 1): S5–S15.
- 9Kim S, Gaber MW, Zawaski JA, Zhang F, Richardson M, Zhang XA, Yang Y. The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acidcomposite biomaterial. Biomaterials 2009; 30: 4743–4751.
- 10Lü S, Liu M, Ni B. An injectable oxidized carboxymethyl cellulose/N-succinyl-chitosan hydrogel system for protein delivery. Chem Eng J 2010; 160: 779–787.
- 11Liu Y, Tian F, Hu KA. Synthesis and characterization of a brush-like copolymer of polylactide grafted onto chitosan. Carbohydr Res 2004; 339: 845–851.
- 12Wu Y, Zheng Y, Yang W, Wang C, Hu J, Fu S. Synthesis and characterization of a novel amphiphilic chitosan–polylactide graft copolymer. Carbohydr Polym 2005; 59: 165–171.
- 13Bhattarai N, Ramay HR, Chou SH, Zhang M. Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery. Int J Nanomed 2006; 1: 181–187.
- 14Ivirico JLE, Salmerón-Sánchez M, Ribelles JG, Pradas MM. Poly(l-lactide) networks with tailored water sorption. Colloid Polym Sci 2009; 287: 671–681.
- 15Yu LM, Kazazian K, Shoichet MS. Peptide surface modification of methacrylamide chitosan for neural tissue engineering applications. J Biomed Mater Res A 2007; 82: 243–255.
- 16Radhakumary C, Nair PD, Mathew S, Nair CP. Biopolymer composite of chitosan and methyl methacrylate for medical applications. Trends Biomater Artif Organs 2005; 18: 117–124.
- 17An J, Yuan X, Luo Q, Wang D. Preparation of chitosan-graft-(methylmethacrylate)/Ag nanocomposite with antimicrobial activity. Polym Int 2010; 59: 62–70.
- 18Hong Y, Song H, Gong Y, Mao Z, Gao C, Shen J. Covalently crosslinked chitosan hydrogel: Properties of in vitro degradation and chondrocyte encapsulation. Acta Biomater 2007; 3: 23–31.
- 19Porstmann B, Jung K, Schmechta H, Evers U, Pergande M, Porstmann T, Kramm HJ, Krause H. Measurement of lysozyme in human body fluids: Comparison of various enzyme immunoassay techniques and their diagnostic application. Clin Biochem 1989; 22: 349–355.
- 20Kowapradit J, Opanasopit P, Ngawhiranpat T, Apirakaramwong A, Rojanarata T, Ruktanonchai U, Sajomsang W. Methylated N-(4-N,N-dimethylaminobenzyl) chitosan, a novel chitosan derivative, enhances paracellular permeability across intestinal epithelial cells (Caco-2). AAPS Pharm Sci Technol 2008; 9: 1143–1152.
- 21Calori GM, Donati D, Di Bella C, Tagliabue L. Bone morphogenetic proteins and tissue engineering: Future directions. Injury 2009; 40: S67–S76.
- 22Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: Emerging safety concerns and lessons learned. Spine J 2011; 11: 471–491.
- 23Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 2006; 31: 542–547.
- 24Lin CC, Metters AT. Hydrogels in controlled release formulations: Network design and mathematical modeling. Adv Drug Deliv Rev 2006; 58: 1379–1408.
- 25Al-Kahtani Ahmed A, Bhojya Naik HS, Sherigara BS. Synthesis and characterization of chitosan-based pH-sensitive semi-interpenetrating network microspheres for controlled release of diclofenac sodium. Carbohydr Res 2009; 344: 699–706.
- 26Guo BL, Gao QY. Preparation and properties of a pH/temperature-responsive carboxymethyl chitosan/poly(N-isopropylacrylamide) semi-IPN hydrogel for oral delivery of drugs. Carbohydr Res 2007; 342: 2416–2422.
- 27Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2001; 48: 139–157.
- 28Stokke BT, Varum KM, Holme HK, Hjerde RJN, Smidsrod O. Sequence specificities for lysozyme depolymerization of partially N-acetylated chitosans. Can J Chem 1995; 73: 1972–1981.
- 29Freier T, Koh HS, Kazazian K, Shoichet MS. Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials 2005; 26: 5872–5878.
- 30Thies RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM, Rosen V. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 1992; 130: 1318–1324.
- 31Kempen DH, Lu L, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 2008; 29: 3245–3252.
- 32Kim S, Tsao H, Kang Y, Young DA, Sen M, Wenke JC, Yang Y. In vitro evaluation of an injectable chitosan gel for sustained local delivery of BMP-2 for osteoblastic differentiation. J Biomed Mater Res B Appl Biomater 2011; 99: 380–390.
- 33Nguyen AH, Kim S, Maloney WJ, Wenke JC, Yang Y. Effect of coadministration of vancomycin and BMP-2 on cocultured Staphylococcus aureus and W-20-17 mouse bone marrow stromal cells in vitro. Antimicrob Agents Chemother 2012; 56: 3776–3784.
- 34Liu R, Ginn SL, Lek M, North KN, Alexander IE, Little DG, Schindeler A. Myoblast sensitivity and fibroblast insensitivity to osteogenic conversion by BMP-2 correlates with the expression of Bmpr-1a. BMC Musculoskelet Disord 2009; 10: 1–12.
- 35Bramono DS, Murali S, Rai B, Ling L, Poh WT, Lim ZX, Stein GS, Nurcombe V, van Wijnen AJ, Cool SM. Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2). Bone 2012; 50: 954–964.
- 36Jeong BC, Lee YS, Park YY, Bae IH, Kim DK, Koo SH, Choi HR, Kim SH, Franceschi RT, Koh JT, Choi HS. The orphan nuclear receptor estrogen receptor-related receptor gamma negatively regulates BMP2-induced osteoblast differentiation and bone formation. J Biol Chem 2009; 284: 14211–14218.
- 37Schindeler A, Liu R, Little DG. The contribution of different cell lineages to bone repair: Exploring a role for muscle stem cells. Differentiation 2009; 77: 12–18.
- 38Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994; 127: 1755–1766.
- 39Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 1991; 113: 681–687.
- 40Bhakta G, Rai B, Lim ZX, Hui JH, Stein GS, van Wijnen AJ, Nurcombe V, Prestwich GD, Cool SM. Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2. Biomaterials 2012; 33: 6113–6122.
- 41Diefenderfer DL, Osyczka AM, Garino JP, Leboy PS. Regulation of BMP-induced transcription in cultured human bone marrow stromal cells. J Bone Joint Surg Am 2003; 85: 19–28.
- 42Osyczka AM, Diefenderfer DL, Bhargave G, Leboy PS. Osteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cells. Cells Tissues Organs 2004; 176: 109–119.
